Multipotent mesenchymal stromal cell therapy and risk of malignancies (Q37975113)

26 August 2017

title

Multipotent mesenchymal stromal cell therapy and risk of malignancies (English)

1 reference

26 August 2017

1 reference

26 August 2017

Federica Casiraghi

1 reference

26 August 2017

Mauro Abbate

series ordinal

1 reference

26 August 2017

Norberto Perico

series ordinal

1 reference

26 August 2017

publication date

1 February 2013

1 reference

Stem Cell Reviews and Reports

26 August 2017

published in

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

page(s)

65-79

1 reference

Mesenchymal stem cells: revisiting history, concepts, and assays.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

21 January 2018

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

"Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Telomerase maintains telomere structure in normal human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Spontaneous transformation of cultured mouse bone marrow-derived stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Sarcoma derived from cultured mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

p53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Biological characterization of long-term cultured human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Molecular characterization of spontaneous mesenchymal stem cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Platelet-derived growth factor BB promotes the migration of bone marrow-derived mesenchymal stem cells towards C6 glioma and up-regulates the expression of intracellular adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Putting tumours in context

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Tumor cell behaviour modulation by mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

NF-kappaB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Effects of transplantation of adipose tissue-derived stem cells on prostate tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Correlation between melanoma angiogenesis and the mesenchymal stem cells and endothelial progenitor cells derived from bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Retracted: Upregulation of PTEN in Glioma Cells by Cord Blood Mesenchymal Stem Cells Inhibits Migration via Downregulation of the PI3K/Akt Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Cord Blood Stem Cell-Mediated Induction of Apoptosis in Glioma Downregulates X-Linked Inhibitor of Apoptosis Protein (XIAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Gene Therapy of Intracranial Glioma Using Interleukin 12–Secreting Human Umbilical Cord Blood–Derived Mesenchymal Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cells and adipogenesis in hemangioma involution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Adipose tissue-derived stem cells promote prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Tissue-resident stem cells promote breast cancer growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Resolution of refractory chronic autoimmune thrombocytopenic purpura following mesenchymal stem cell transplantation: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Wound therapy by marrow mesenchymal cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9345-4

Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon

21 January 2018

1 reference

12 December 2020

Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery.

1 reference

12 December 2020

Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use

1 reference

12 December 2020

Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction.

1 reference

12 December 2020

Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells

1 reference

12 December 2020

Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report

1 reference

12 December 2020

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

12 December 2020

The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells

1 reference

12 December 2020

Possibilities for the use of autologous mesenchymal stem cells in the therapy of radiation-induced lung injuries

1 reference

12 December 2020

Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatc

1 reference

12 December 2020

Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation

1 reference

12 December 2020

Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study

1 reference

12 December 2020

Spontaneous human adult stem cell transformation.

1 reference

12 December 2020

A Phase I Clinical Trial of the Treatment of Crohn's Fistula by Adipose Mesenchymal Stem Cell Transplantation

1 reference

12 December 2020

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

1 reference

12 December 2020

Stem cell treatment in Amyotrophic Lateral Sclerosis

1 reference

12 December 2020

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study

1 reference

12 December 2020

1 reference

12 December 2020

Cotransplantation of haploidentical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemia

1 reference

12 December 2020

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy

1 reference

12 December 2020

Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells

1 reference

12 December 2020

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

1 reference

12 December 2020

Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study

1 reference

12 December 2020

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome

1 reference

12 December 2020

Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo.

1 reference

12 December 2020

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

12 December 2020

Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus

1 reference

12 December 2020

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

1 reference

12 December 2020

Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium

1 reference

12 December 2020

Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study

1 reference

12 December 2020

Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot

1 reference

12 December 2020

Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction

1 reference

12 December 2020

Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients

1 reference

12 December 2020

Autologous mesenchymal stem cell transplantation in stroke patients

1 reference

12 December 2020

Safety of Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Animals and Humans

1 reference

12 December 2020

Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.

1 reference

12 December 2020

Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma

1 reference

12 December 2020

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas

1 reference

12 December 2020

Spontaneous Malignant Transformation of Human Mesenchymal Stem Cells Reflects Cross-Contamination: Putting the Research Field on Track - Letter

1 reference

12 December 2020

10.1007/S12015-011-9345-4

Identifiers

DOI

1 reference

26 August 2017

1 reference